A Randomized, Double-blind, Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone Treatment of Overt Hepatic Encephalopathy

Trial Profile

A Randomized, Double-blind, Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone Treatment of Overt Hepatic Encephalopathy

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Nitazoxanide (Primary) ; Lactulose
  • Indications Hepatic encephalopathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 17 Oct 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 09 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top